Targeting mitochondrial Kv1.3 enables precise autoreactive T cell therapy for multiple sclerosis
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Nature Publishing Group UK
Abstract
Description
Multiple sclerosis (MS), a chronic autoimmune disorder, is characterized by the infiltration of autoreactive T cells into the central nervous system (CNS), leading to myelin destruction and neurological deficits. Current therapies often lack specificity, resulting in broad immunosuppression and potential side effects. In this issue of EMBO Molecular Medicine, Angi, Varanita and colleagues (Angi et al, 2025) identify a novel therapeutic strategy in targeting the mitochondrial Kv1.3 channel in autoreactive T cells, offering a more selective approach to mitigate MS-like pathology.